A Phase III trial of A-101 (45% topical solution) for the treatment of warts
Phase of Trial: Phase III
Latest Information Update: 08 May 2018
At a glance
- Drugs Hydrogen peroxide (Primary)
- Indications Warts
- Focus Therapeutic Use
- 08 May 2018 According to an Aclaris Therapeutics media release, company expects to initiate this trial in the second half of 2018.
- 23 Mar 2018 New trial record
- 19 Mar 2018 According to an Aclaris Therapeutics media release, the Company expects to initiate the Phase III program in second quarter of 2018.